4174.TWO · OBI
Taiwan · RS rating 89 · As of 2026-10-08
| Price | 53.70 TWD |
|---|---|
| 1-day change | +3.1% |
| RS rating (overall / 1M / 3M / 12M) | 89 / 99 / 98 / 56 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 50 / 42 / 55 |
| Industry group (rank) | Medical-Biomed/Biotech (53) |
| EPS growth Q/Q | +55.2% |
| Sales growth Q/Q | +174.6% |
| Distance from 52-week high | +15.6% |
| Market cap (USD) | $173.1M |